Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 2933771)

Published in Can Respir J on September 02, 2010

Authors

Darcy D Marciniuk1, Dina Brooks, Scott Butcher, Richard Debigare, Gail Dechman, Gordon Ford, Veronique Pepin, Darlene Reid, Andrew W Sheel, Micheal K Stickland, David C Todd, Shannon L Walker, Shawn D Aaron, Meyer Balter, Jean Bourbeau, Paul Hernandez, Francois Maltais, Denis E O'Donnell, Donna Bleakney, Brian Carlin, Roger Goldstein, Stella K Muthuri, Canadian Thoracic Society COPD Committee Expert Working Group

Author Affiliations

1: University of Saskatchewan, Saskatoon, Saskatchewan. ctsinfo@lung.ca

Associated clinical trials:

Optimization of Pulmonary Rehabilitation Programmes: the OPTION Study (OPTION) | NCT01933308

Articles citing this

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32

Diagnosing and treating COPD: understanding the challenges and finding solutions. Int J Gen Med (2011) 1.10

Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews. Int J Chron Obstruct Pulmon Dis (2012) 0.92

Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses. Int J Chron Obstruct Pulmon Dis (2015) 0.84

Pulmonary rehabilitation in Canada: A report from the Canadian Thoracic Society COPD Clinical Assembly. Can Respir J (2015) 0.83

Effect of physical training on airway inflammation in bronchial asthma: a systematic review. BMC Pulm Med (2013) 0.82

A combination of resistance and endurance training increases leg muscle strength in COPD: An evidence-based recommendation based on systematic review with meta-analyses. Chron Respir Dis (2015) 0.79

Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review. Syst Rev (2016) 0.75

Magnitude of exercise capacity and quality of life improvement following repeat pulmonary rehabilitation in patients with COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75

Optimizing nonpharmacological management following an acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2014) 0.75

Non-pharmacological management of chronic obstructive pulmonary disease. Ulster Med J (2015) 0.75

Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations. NPJ Prim Care Respir Med (2015) 0.75

Clinical Decision-Making Tool for Safe and Effective Prescription of Exercise in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Results From an Interdisciplinary Delphi Survey and Focus Groups. Phys Ther (2015) 0.75

Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey. Ont Health Technol Assess Ser (2015) 0.75

Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: a meta-analysis. Int J Chron Obstruct Pulmon Dis (2016) 0.75

Respiratory Muscle Strength in Patients With Chronic Obstructive Pulmonary Disease. Ann Rehabil Med (2017) 0.75

Articles cited by this

Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet (2009) 11.72

A new system for grading recommendations in evidence based guidelines. BMJ (2001) 11.13

AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ (2010) 8.73

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65

We need minimally disruptive medicine. BMJ (2009) 5.35

Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27

Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2008) 4.12

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67

Evidence based? Caveat emptor! Health Aff (Millwood) (2005) 2.77

Exacerbations of chronic obstructive pulmonary disease. Eur Respir J (2007) 2.65

Gender and COPD in patients attending a pulmonary clinic. Chest (2005) 2.59

Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50

Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ (2004) 2.18

The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med (2007) 2.09

A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD. A follow-up of 18 months. Chest (1996) 2.08

Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2009) 1.98

Pulmonary rehabilitation-1999. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.88

Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82

Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax (2010) 1.79

Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J (2007) 1.76

Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med (2003) 1.60

Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J (1998) 1.55

The effect of single set resistance training on strength and functional fitness in pulmonary rehabilitation patients. J Cardiopulm Rehabil (2006) 1.50

Four weeks' intensive rehabilitation generates significant health effects in COPD patients. Chron Respir Dis (2007) 1.48

Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.45

A randomized, controlled trial comparing long-term and short-term exercise in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2003) 1.32

Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med (1999) 1.32

Predictors of poor attendance at an outpatient pulmonary rehabilitation programme. Respir Med (2008) 1.21

Rehabilitation of patients admitted to a respiratory intensive care unit. Arch Phys Med Rehabil (1998) 1.19

Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med (2000) 1.15

Endurance and strength training in patients with COPD. Chest (2004) 1.07

Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 1.07

Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med (2009) 1.06

The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest (2005) 1.05

Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study. Respirology (2009) 1.05

The effects of resistance training on functional outcomes in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol (2003) 1.00

A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax (2001) 0.99

Exercise training improves recovery in patients with COPD after an acute exacerbation. Respir Med (1998) 0.98

The long-term benefits of outpatient pulmonary rehabilitation on exercise endurance and quality of life. Chest (1993) 0.97

Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir Med (2005) 0.93

Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest (2001) 0.92

Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD. Monaldi Arch Chest Dis (2003) 0.91

[Home vs hospital-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a Spanish multicenter trial]. Arch Bronconeumol (2008) 0.91

Fluid intelligence in an older COPD sample after short- or long-term exercise. Med Sci Sports Exerc (2001) 0.89

Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch Chest Dis (2003) 0.88

Gender-specific issues in cardiac rehabilitation: do women with ischaemic heart disease need specially tailored programmes? Eur J Cardiovasc Prev Rehabil (2007) 0.86

Physiological response to moderate exercise workloads in a pulmonary rehabilitation program in patients with varying degrees of airflow obstruction. Chest (1999) 0.85

Gender considerations in pulmonary rehabilitation. J Cardiopulm Rehabil Prev (2008) 0.83

Two different training programmes for patients with COPD: a randomised study with 1-year follow-up. Respir Med (2006) 0.82

How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax (2006) 0.82

Chronic obstructive pulmonary disease in women. Can Respir J (2007) 0.81

Meta-analysis of the effects of respiratory rehabilitation programmes on exercise capacity in accordance with programme characteristics. J Clin Nurs (2007) 0.80

Female and male chronic obstructive pulmonary disease patients with severe dyspnea do not profit less from pulmonary rehabilitation. Pol Arch Med Wewn (2008) 0.78

Pulmonary rehabilitation. Does the site matter? Chest (1996) 0.77

Exhaled nitric oxide and exercise tolerance in severe COPD patients. Respir Med (2002) 0.77

Short- and long-term hospital and community exercise programmes for patients with chronic obstructive pulmonary disease. Respirology (2004) 0.76

Articles by these authors

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51

Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ (2002) 4.70

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27

Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2008) 4.12

A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.85

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62

Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 3.61

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51

High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med (2002) 3.43

Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. Can Respir J (2003) 3.14

A randomized controlled trial of balance training during pulmonary rehabilitation for individuals with COPD. Chest (2013) 3.03

Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest (2004) 2.98

Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD. Chest (2013) 2.42

Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest (2008) 2.37

Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32

Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J (2013) 2.20

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest (2005) 2.15

Pulmonary rehabilitation: a review of the recent literature. Chest (2012) 2.13

Measurement properties and interpretability of the Chronic respiratory disease questionnaire (CRQ). COPD (2005) 2.12

Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest (2006) 2.08

Self-management programmes for COPD: moving forward. Chron Respir Dis (2012) 2.07

Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother (2006) 2.05

Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest (2002) 2.02

Evaluation of gait symmetry after stroke: a comparison of current methods and recommendations for standardization. Gait Posture (2009) 1.99

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.97

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.97

Effectiveness of acute geriatric unit care using acute care for elders components: a systematic review and meta-analysis. J Am Geriatr Soc (2012) 1.91

Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med (2008) 1.90

Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85

ATS statement on six-minute walk test. Am J Respir Crit Care Med (2003) 1.84

Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J (2011) 1.83

Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax (2011) 1.82

Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med (2010) 1.80

Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med (2007) 1.80

Overdiagnosis of asthma in the community. Can Respir J (2004) 1.80

Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med (2009) 1.79

A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol (2005) 1.76

Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J (2007) 1.76

Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2012) 1.75

Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol (2003) 1.75

Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med (2007) 1.74

Pulmonary function testing in the diagnosis of asthma: a population study. Chest (2011) 1.72

Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med (2008) 1.67

Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol (1985) (2007) 1.67

Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest (2005) 1.67

A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods. Can Respir J (2005) 1.63

A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events. Acad Emerg Med (2013) 1.59

Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med (2013) 1.59

Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage (2011) 1.59

Effects of written action plan adherence on COPD exacerbation recovery. Thorax (2010) 1.57

Use of the six-minute walk test poststroke: is there a practice effect? Arch Phys Med Rehabil (2008) 1.57

The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest (2009) 1.56

Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Can Respir J (2004) 1.55

A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med (2005) 1.54

Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985) (2011) 1.53

Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51

Measurement of activities of daily living in patients with COPD: a systematic review. Chest (2014) 1.50

Pre-coronary artery bypass graft measures and enrollment in cardiac rehabilitation. J Cardiopulm Rehabil (2005) 1.50

Academic Dishonesty among Physical Therapy Students: A Descriptive Study. Physiother Can (2012) 1.50

Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis. Eur J Prev Cardiol (2011) 1.49

Reliability and validity of the AGREE instrument used by physical therapists in assessment of clinical practice guidelines. BMC Health Serv Res (2005) 1.49

Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol (2005) 1.48

Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med (2002) 1.47

American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest (2010) 1.46

Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax (2011) 1.46